HighPoint Advisor Group’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $256K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $202K | Buy |
|
|||||
|
2024
Q3 | $254K | Buy |
|
|||||
|
2024
Q2 | $257K | Sell |
|
|||||
|
2024
Q1 | $255K | Buy |
|
|||||
|
2023
Q4 | $307K | Buy |
|
|||||
|
2022
Q2 | $278K | Buy |
|
|||||
|
2021
Q3 | $922K | Buy |
|
|||||
|
2021
Q2 | $1.29M | Sell |
|
|||||
|
2021
Q1 | $943K | Buy |
|
|||||
|
2020
Q4 | $1.03M | Buy |
|
|||||
|
2020
Q3 | $609K | Buy |
|
|||||
|
2020
Q2 | $416K | Buy |
|
|||||
|
2020
Q1 | $278K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $171K | Buy |
|
|||||
|
2019
Q2 | $130K | Buy |
|